Dr Reddy's Laboratories Limited (NYSE: RDY), Srikakulam, India – FDA Inspections
Inspection records and compliance data for Dr Reddy's Laboratories Limited in Srikakulam. 7 FDA inspections on record, 4 Form 483s, last inspected December 12, 2025. Publicly traded as NYSE: RDY.
This profile covers Dr Reddy's Laboratories Limited based in Srikakulam, India.
FDA Inspection History
- FDA inspections
- 7
- OAI
- 0
- VAI
- 3
- NAI
- 2
- Unclassified
- 2
- Form 483s
- 4
- Warning letters
- 0
First inspected November 14, 2014. Last inspected December 12, 2025.
Most cited issue areas
- Computer control of master formula records1 inspection
- Investigations of discrepancies, failures1 inspection
- Scientifically sound laboratory controls1 inspection
FDA inspections (7)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| December 12, 2025 | Not classified | Human Drugs | 1297022 |
| August 23, 2024 | Not classified | Human Drugs | 1250569 |
| May 20, 2022 | VAI | Human Drugs · Drug Quality Assurance | 1230622 |
| February 14, 2020 | NAI | Human Drugs · Drug Quality Assurance | 1122262 |
| January 15, 2019 | VAI | Human Drugs · Drug Quality Assurance | 1076343 |
| June 16, 2017 | VAI | Human Drugs · Drug Quality Assurance | 1018229 |
| November 14, 2014 | NAI | Human Drugs · Drug Quality Assurance | 904970 |
Companies with similar regulatory profiles, compliance history, and operations.
Name
Dr Reddy's Laboratories Limited
Stock ticker
RDY
Exchange
NYSE
Share price
$14.73
Market cap
$12.3B
Price as of
November 13, 2026
FEI Number
3009193040
Address
FTO-Sez Process Unit-01, Survey No 57 to 59,60,62&72, Sector No 9 to 14 & 17 to 20,, Devunipalavalasa Village Ranasthalam(M), Srikakulam, India
Country
India
ID: 97f3d461-62f0-4198-9e9d-7f7c7d43af86